P2B001 (low dose combination of extended-release pramipexole and rasagiline) versus titrated extended-release pramipexole in the management of early Parkinson's disease: Exploratory findings from a randomized, controlled trial

被引：0
|
作者：
Elmer, Lawrence [1 ]
Litman, Pninit [2 ]
Friedman, Hadas [2 ]
Fitzer-Attas, Cheryl [2 ]
Oren, Sheila [2 ]
机构：
[1] Univ Toledo, Coll Med & Life Sci, Dept Neurol, Toledo, OH USA
[2] Pharma Two B, Rehovot, Israel
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203489
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S32.010
引用
收藏
页数：4
相关论文
共 41 条
  • [21] Efficacy and safety of pramipexole extended-release in Parkinson's disease: a review based on meta-analysis of randomized controlled trials
    Shen, T.
    Ye, R.
    Zhang, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (06) : 835 - 843
  • [22] Easy switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage
    Rascol, O.
    Barone, P.
    Debieuvre, C.
    Hauser, R. A.
    Mizuno, Y.
    Poewe, W.
    Salin, L.
    Schapira, A.
    Sohr, M.
    MOVEMENT DISORDERS, 2009, 24 : S362 - S362
  • [23] Dosage, safety, and tolerability for overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease
    Rascol, O.
    Barone, P.
    Debieuvre, C.
    Hauser, R.
    Mizuno, Y.
    Poewe, W.
    Salin, L.
    Schapira, A.
    Sohr, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 30 - 30
  • [24] Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Rascol, O.
    Busse, M.
    Debieuvre, C.
    Fraessdorf, M.
    Schapira, A.
    MOVEMENT DISORDERS, 2011, 26 : S137 - S138
  • [25] Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
    Hauser, R. A.
    Schapira, A. H. V.
    Barone, P.
    Mizuno, Y.
    Rascol, O.
    Busse, M.
    Debieuvre, C.
    Fraessdorf, M.
    Poewe, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (05) : 736 - 743
  • [26] Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage
    Rascol, O.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Poewe, W.
    Schapira, A.
    Debieuvre, C.
    Sohr, M.
    Salin, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S131 - S132
  • [27] Usefulness of rapid switch from ergot dopamine agonists to pramipexole extended-release preparation in patients with Parkinson's disease
    Saiki, H.
    Matsumoto, S.
    MOVEMENT DISORDERS, 2013, 28 : S153 - S153
  • [28] Long-Term Efficacy and Safety of Pramipexole Extended-Release in Advanced Parkinson's Disease: An Open-Label Trial
    Schapira, Anthony
    Barone, Paolo
    Hauser, Robert
    Mizuno, Youshikuni
    Rascol, Olivier
    Busse, Michael
    Salin, Laurence
    Sohr, Mandy
    Poewe, Werner
    NEUROLOGY, 2010, 74 (09) : A349 - A350
  • [29] Efficacy, Safety, and Tolerability of Overnight Switching from Immediate- to Once Daily Extended-Release Pramipexole in Early Parkinson's Disease
    Rascol, Olivier
    Barone, Paolo
    Hauser, Robert A.
    Mizuno, Yoshikuni
    Poewe, Werner
    Schapira, Anthony H. V.
    Salin, Laurence
    Sohr, Mandy
    Debieuvre, Catherine
    MOVEMENT DISORDERS, 2010, 25 (14) : 2326 - 2332
  • [30] Success rate, efficacy, and safety/tolerability of overnight switching from immediate-to extended-release pramipexole in advanced Parkinson's disease
    Schapira, A. H. V.
    Barone, P.
    Hauser, R. A.
    Mizuno, Y.
    Rascol, O.
    Busse, M.
    Debieuvre, C.
    Fraessdorf, M.
    Poewe, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (01) : 180 - 187
12345